title: Clinical features and outcome of acute hepatitis B in pregnancy.
abstract: BACKGROUND
  The impact of pregnancy on the clinical course of acute hepatitis B (AHB) is still largely unclear, mainly because most studies have not included matched controls. This study was conducted to investigate the clinical features and outcome of AHB in pregnancy using matched controls.
  
  
  METHODS
  Consecutive AHB inpatients who were admitted to Jinan Infectious Disease Hospital, Jinan, between January 2006 and December 2010 were evaluated and followed. Demographic data, clinical manifestations, and results of laboratory tests were compared between pregnant patients and age and sex matched non-pregnant patients at admission, discharge, and final follow-up.
  
  
  RESULTS
  A total of 618 AHB inpatients were identified during the study period. 22 pregnant patients and 87 age and sex matched non-pregnant patients were enrolled in this study. Prodromal fever was less common (0% vs. 20.7%, P=0.02), serum alanine aminotransferase levels were significantly lower, and HBsAg>250 IU/mL rate and serum bilirubin levels were significantly higher in pregnant patients than in non-pregnant patients. After a mean (range) of 7(5.2-8.3) months follow-up, 18.2% pregnant patients and 4.6% non-pregnant patients were still HBsAg positive (P=0.03). For pregnant patients, the relative risk (95% confidence interval) of HBsAg positive at the end of follow-up was 4.6 (1.1-20.2). The median (95% confidence interval) days of HBsAg seroclearance form disease onset in pregnant and non-pregnant patients were 145.0 (110.5-179.5) and 80.0 (62.6-97.4), respectively.
  
  
  CONCLUSIONS
  The HBsAg loss and seroconversion were delayed and lower in pregnant patients. Pregnancy might be a possible risk of chronicity following acute HBV infection.
authors.forename: Yong-Tao
authors.initials: YT
authors.lastname: Han
authors.forename: Chao
authors.initials: C
authors.lastname: Sun
authors.forename: Cai-Xia
authors.initials: CX
authors.lastname: Liu
authors.forename: Shuang-Shuang
authors.initials: SS
authors.lastname: Xie
authors.forename: Di
authors.initials: D
authors.lastname: Xiao
authors.forename: Li
authors.initials: L
authors.lastname: Liu
authors.forename: Jin-Hong
authors.initials: JH
authors.lastname: Yu
authors.forename: Wen-Wen
authors.initials: WW
authors.lastname: Li
authors.affiliation: Division of Liver Disease, Jinan Infectious Disease Hospital, Shandong University, Jinan, China. doctorliqiang@gmail.com.
authors.forename: Qiang
authors.initials: Q
authors.lastname: Li
mesh_terms: D000328:Adult; D016022:Case-Control Studies; D004279:DNA, Viral / Q000097:blood; D005260:Female; D006509:Hepatitis B / Q000097:blood* / Q000276:immunology*; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000097:blood / Q000276:immunology / Q000821:virology*; D055815:Young Adult
chemical_list: D004279:DNA, Viral; D006514:Hepatitis B Surface Antigens